Marché mondial du traitement de la varicelle – Tendances et prévisions du secteur jusqu’en 2030

Analyse et taille du marché du traitement de la varicelle

Selon les Centres pour le contrôle et la prévention des maladies, en mai 2021, le zona touchait les personnes âgées de 60 ans et plus à un taux d'environ 1 sur 100 aux États-Unis chaque année. Les personnes âgées sont plus sensibles au zona en raison de l'affaiblissement de leur système immunitaire. La demande croissante de vaccination dans de nombreux pays devrait stimuler la demande pour le marché du traitement de la varicelle dans les années à venir.

Data Bridge Market Research analyse le taux de croissance du marché du traitement de la varicelle au cours de la période de prévision 2023-2030. Le TCAC attendu du marché du traitement de la varicelle tend à être d'environ 4,50 % au cours de la période de prévision mentionnée. Le marché était évalué à 1,6 milliard USD en 2022 et atteindrait 2,28 milliards USD d'ici 2030. En plus des informations sur le marché telles que la valeur marchande, le taux de croissance, les segments de marché, la couverture géographique, les acteurs du marché et le scénario du marché, le rapport de marché organisé par l'équipe de Data Bridge Market Research comprend également une analyse approfondie des experts, l'épidémiologie des patients, l'analyse du pipeline, l'analyse des prix et le cadre réglementaire.

Portée et segmentation du marché du traitement de la varicelle

Market Definition

Varicella, also known as chickenpox, is an acute and highly contagious disease caused by the primary infection of varicella-zoster virus (VZV). It is highly transmissible through respiratory droplets or may infect another person through direct contact. The initial symptoms of clinical varicella generally appear after a 10-21-day incubation period, including fever, malaise, and the characteristic itchy rash.  

Global Varicella Treatment Market Dynamics

Drivers

• Growing Awareness About Vaccines

Varicella vaccines are primarily used for measles, chickenpox, herpes zoster and mumps, rubella, and varicella immunization. Chickenpox can be serious, particularly in babies, adults, pregnant women, adolescents, and people with low immunity systems. Thus immunization in newborns is recommended by the WHO. Growing awareness associated with the use of varicella vaccines, growing immunization programs, and the rise in adoption of varicella vaccination worldwide also boost the growth of the varicella treatment market.

• Immunization Towards Chickenpox

Varicella vaccines are more efficient in building immunity against the varicella-zoster virus as the infection can cause severe diseases such as chickenpox and herpes zoster. Immunization against these diseases is essential as chickenpox can lead to severe complications such as bacterial infections of the skin and soft tissues in children and is also seen in adults in tropical countries like India. Growing demand for vaccination in many countries is anticipated to boost the demand for the varicella market in the upcoming years.

Opportunities

• Rising Rate of Campaigns and Initiatives

There are numerous campaigns that are being conducted in the U.S. to immunize people against the varicella vaccine to prevent diseases. For Instance, in October 2021, Measles, mumps, rubella (MMR), and varicella (chickenpox) vaccinations for Afghan evacuate who are temporarily staying at eight military installations in the U.S. were administered nationwide as part of Operation Allies Welcome (OAW). This effort led to the vaccination of more than 49,000 Afghan refugees nationwide. Furthermore, vaccinations are being given to evacuates at staging locations in Europe and the Middle East.

• Increasing Demand for Retail Pharmacies

The rise in the number of varicella therapeutics delivered through retail pharmacies and more retail pharmacies in highly developed countries creates opportunities for market expansion. Additionally, patients choose retail pharmacies over other types for purchasing drugs, as these are easily available.

 Restraints/Challenges

• Lack of skilled professionals

The lack of appropriate healthcare professionals who are unable to treat the patients with suitable treatments could limit the growth of the global varicella treatment market over a forecast period.

• Unavailability of Vaccinations

There is wide unavailability of vaccines that is hampering the market growth. Vaccination for varicella is not available in these regions. It was recorded that Thailand, Timor Lester, Macedonia, Tajikistan, and Syria accounted for the biggest number of varicella infection cases as of 2013, but there was a lack of vaccines and medicines that hampered the market growth.

This global varicella treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global varicella treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Global Varicella Treatment Market

The SARS-CoV-2 that causes coronavirus disease has been associated with T-cell immunological dysfunction. Patients suffering from COVID-19 are more likely to experience reactivation of herpes zoster due to the functional impairment and decline in T lymphocytes, predominantly CD4+ T cells, CD8+ T cells, and natural killer cells. Furthermore, the study titled "Herpes zoster in the era of COVID-19: A prospective observational study to probe the association of herpes zoster with COVID 19 infection and vaccination" published in the National Library of Medicine in June 2022, it has been reported that during post-marketing surveillance, reactivation of the varicella-zoster virus has occasionally been reported post vaccination for SARS-CoV-2. Thus, during the ongoing COVID-19 outbreak, managing varicella infection has become more critical.

Recent Developments:

• In January 2022, Pfizer Inc. collaborated with BioNTech S.E. to develop a potential first mRNA-based vaccine for the prevention of shingles, a debilitating, disfiguring, and painful disease which impacts about one in three people in the U.S. during their lifetime.
• In July 2021, GlaxoSmithKline plc reported that the U.S. FDA had approved Shingrix to prevent herpes zoster in adults aged 18 years and above who are at higher risk of developing the disorder because of immunodeficiency

Global Varicella Treatment Market Scope

The global varicella treatment market is segmented on the basis of treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Treatment

• Vaccines
• Medication
• Others

Route of Administration

• Oral
• Topical
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Varicella Treatment Market Regional Analysis/Insights

The global varicella treatment market is analyzed and market size insights and trends are provided by treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global varicella treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has witnessed positive global varicella treatment market growth throughout the forecasted period due to major key players and increased healthcare expenditure.

Asia-Pacific dominates the market due to the increased prevalence of varicella infection and easily availability of drugs in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Varicella Treatment Market Share Analysis

The global varicella treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global varicella treatment market

Key players operating in the global varicella treatment market include:

• Mylan N.V. (U.S.)

• Teva Pharmaceutical Industries Ltd. (Israel)
• Sanofi (France)
• Novartis AG (Switzerland)
• GSK plc (U.K.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Takeda Pharmaceutical Company Limited (Japan)
• BIO-MED (India)
• Intercept Pharmaceuticals, Inc (U.K.)
• Emcure Pharmaceuticals Limited(India)
• Changchun BCHT Biotechnology Co. (China)
• Novo Medi Sciences (India)

Research Methodology: Global Varicella Treatment Market  

La collecte des données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. Les données du marché sont analysées et estimées à l'aide de modèles statistiques et cohérents du marché. L'analyse des parts de marché et l'analyse des tendances clés sont également les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.

La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données, qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). En dehors de cela, les modèles de données comprennent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement de l'entreprise, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et la part des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande de renseignements pour parler à nos experts du secteur.

Personnalisation disponible

Data Bridge Market Research est un leader dans la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'aux stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez pour obtenir des données dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Factbook) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.

SKU-55676